Hepatobiliary Disease and Liver Failure

Alcohol-Associated Liver Disease (ALD)

Chronic, heavy ethanol exposure is a major cause of liver disease. While the liver has a high regenerative capacity, excessive metabolism of alcohol produces toxic by-products like acetaldehyde and reactive oxygen species (ROS). ALD typically progresses through three distinct phases:

1. Steatotic Liver Disease: This is the earliest stage, characterized by the accumulation of fat within hepatocytes. This occurs because the liver diverts enzymes and the $NAD^+$ co-enzyme away from fat metabolism to prioritize alcohol metabolism, leading to decreased $\beta$-oxidation of fatty acids and increased triglyceride synthesis.
2. Alcohol-Associated Hepatitis: An intermediate stage involving inflammation and necrosis of liver cells. A hallmark pathological finding in this stage is the presence of Mallory bodies.
3. Cirrhosis: The final, severe stage involving permanent scarring, jaundice, and potential hepatic failure.

Hepatitis and Viral Pathologies

Hepatitis refers to the inflammation of the liver, which can be classified as acute, chronic (lasting $>6$ months), or fulminant (rapidly progressing). While toxins and autoimmune diseases are causes, viral infections are among the most common etiologies.

Viral Hepatitis Overview

There are five primary hepatotropic viruses (A through E) that affect the liver. They differ significantly in their mode of transmission and their ability to cause chronic disease:

• Hepatitis A (HAV): An unenveloped RNA virus transmitted via the fecal-oral route (e.g., contaminated food or water). It is a benign, self-limiting disease that does not cause chronic infection or a carrier state.
• Hepatitis B (HBV): An enveloped DNA virus transmitted through blood, sexual fluids, or from mother to child. It can lead to acute, chronic, or fulminant hepatitis. A key diagnostic marker is HBsAg (surface antigen), which indicates an active infection.
• Hepatitis C (HCV): An enveloped RNA virus with a high rate of progression; approximately $80%$ of patients progress to chronic disease, which can lead to cirrhosis and hepatocellular carcinoma. Unlike HBV, there is currently no vaccine for HCV.
• Hepatitis D (HDV): An RNA virus that is unique because it can only cause infection in the presence of HBV. It can cause co-infection or super-infection (on top of chronic HBV), often accelerating liver disease.
• Hepatitis E (HEV): An unenveloped RNA virus transmitted via the fecal-oral route, similar to HAV. While generally self-limiting, it carries a high mortality rate (approx. 20%) in pregnant females.

Drug-Related Liver Damage

Because the liver is the body's primary detoxification organ, it is highly susceptible to damage from pharmaceutical and environmental chemicals. Damage can occur through direct toxicity or through biotransformation, where the liver's own metabolic processes convert a drug into a toxic by-product.

Acetaminophen Toxicity

A critical clinical example is acetaminophen overdose, which accounts for a significant portion of acute liver failure cases.

Under normal therapeutic doses, acetaminophen is metabolized by P450 enzymes into a toxic metabolite. This metabolite is then neutralized by glutathione (GSH) to form a harmless substance. However, in an overdose scenario:

1. The standard metabolic pathways become saturated.
2. Glutathione (GSH) reserves are depleted.
3. The toxic metabolite accumulates, causing massive oxidative damage to hepatocytes.

Exam Tip: Acetaminophen Treatment If a patient presents with acetaminophen toxicity, two key treatments are often used:

1. Activated charcoal: To prevent further absorption of the drug.
2. N-acetylcysteine (NAC): The specific antidote that works by replenishing the liver's glutathione (GSH) stores.